ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
15 announcements
Balrampur Chini Mills has sent a reminder intimation to physical shareholders, requesting them to update their KYC details and claim unpaid dividends or shares as mandated.
BCML received a ₹75 Crore BioE3 grant from BIRAC/DBT for a 100 TPA PLA R&D facility at Kumbhi, UP. It will advance India's biopolymer innovation and commercialisation.
Balrampur Chini Mills Limited has confirmed the full and timely repayment of Commercial Paper maturing on 18th September 2026, amounting to ₹100 Crore.
Balrampur Chini Mills held its 50th AGM on September 16, 2026. The meeting transacted several ordinary and special business items, including re-appointments and financial statement adoption.
Balrampur Chini Mills Limited received an ESG rating upgrade to 'Crisil ESG 69' (Category: Strong) from Crisil ESG Ratings & Analytics Limited.
Balrampur Chini reported stable Q1 FY27 performance with improved revenues in Sugar and Distillery segments. Strategy focuses on maximizing cane value and commissioning a new 80,000-tonne PLA plant by December 2026.
Balrampur Chini Mills Ltd reported revenue from operations of ₹1,637 Cr (+6.1% YoY) and net profit of ₹44.1 Cr (-14.5% YoY) for Q1 FY27.
Balrampur Chini is pivoting from sugar to high-margin PLA bioplastics despite stagnant ethanol pricing. Management displays high confidence in the integrated model amid record-low sugar inventory and upcoming 1080 Cr capex completion.
Balrampur Chini Mills reported FY26 revenue of ₹6,271cr with EBITDA of ₹741cr. The company is diversifying into Bioplastics (PLA) with a 250 TPD plant under implementation to create new revenue streams.
Balrampur Chini Mills reported Q4 & FY26 results focusing on sugar production growth and a major pivot towards a ₹3,080 crore PLA (bioplastic) project.
Balrampur Chini is pivoting from a traditional sugar player to a high-margin PLA bioplastic producer. While sugar yields face challenges, management is pinning its future on a ₹3,080 crore capital pivot.
Management is pivoting toward high-margin bio-plastics (PLA) and gypsum, raising ₹450cr to offset a ₹230cr project cost overrun and ensure liquidity.
Management is navigating a ₹230cr cost overrun on the PLA project by diversifying into gypsum boards and raising ₹450cr in equity to maintain liquidity and credit ratings.
Update call on PLA project and capital raising initiatives following Board approval on April 23, 2026. Company is diversifying into bioplastics and value-added by-products.
Management is pivoting toward high-margin bio-plastics and gypsum board production to offset sugar volatility, despite a ₹230 crore cost overrun on the PLA project.